無症狀性市場規模、佔有率和成長分析：按診斷、治療、風險群、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球無症狀性心肌梗塞市場規模為 78.3 億美元，預計到 2025 年將成長至 83.7 億美元，到 2033 年將成長至 142.7 億美元，在預測期（2026-2033 年）內複合年成長率為 6.9%。

無症狀性心肌梗塞解決方案市場涵蓋了用於診斷、監測和治療未被發現的心肌梗塞的方案，這些心肌梗塞通常不會出現典型的胸痛症狀。鑑於大量心肌梗塞病例被漏診，對穿戴式心電圖貼片和人工智慧風險評分系統等早期療育工具的需求激增，凸顯了這些工具能夠為患者和臨床醫生節省成本。這一趨勢標誌著心血管健康管理正從被動應對轉向主動預防。政府對預防性心臟病學的監管支持是推動市場成長的主要動力，因為各國政府意識到早期發現能夠最大限度地降低長期醫療保健成本。諸如高敏肌鈣蛋白檢測的醫療覆蓋範圍以及遠端監測系統的推薦等舉措，正在鼓勵製造商擴大生產規模並加快創新投資，最終改善患者預後並吸引保險公司的注意。

全球無症狀性心肌梗塞市場成長要素

全球65歲及以上人口的不斷成長顯著推高了無症狀性心肌梗塞的發生率。這一人口趨勢提高了醫護人員和看護者對早期檢測重要性的認知。因此，市場對創新無症狀性心肌梗塞監測設備、預測分析和預防性療法的需求日益成長。這種日益成長的需求促使製造商加快創新步伐，拓展分銷網路，隨著這些先進工具在臨床和居家照護環境中得到更廣泛的應用，市場也將隨之成長，最終改善患者預後，並提高公眾對無症狀性心肌梗塞的認知。

全球無症狀性心肌梗塞市場的限制因素

用於檢測無症狀性心肌梗塞的設備由於其複雜精密的特性，對醫療機構而言，其部署和維護成本往往很高。尤其是在公立或資源有限的醫療機構中，預算限制經營團隊優先考慮基本服務而非昂貴的專業技術。這種經濟負擔阻礙了新設備在臨床環境中的應用，限制了患者的就醫途徑，並減緩了整體市場成長。因此，製造商，尤其是在新興市場，如果沒有明確的成本效益證據和足夠的保險報銷支持，很難實現這些創新技術的快速市場滲透。

全球無症狀性心肌梗塞市場趨勢

全球無症狀性心肌梗塞（AMYI）市場正經歷一場重大變革，其驅動力在於人工智慧技術與早期檢測和調查方法的融合。醫療服務提供者正利用複雜的演算法分析來自無症狀性感測器的數據，以識別AMYI的細微徵兆。透過持續監測心率變異性和微血管壓力標記物，這些人工智慧平台能夠實現即時風險評估，並促進及時預防性護理。這種向人工智慧驅動的監測方式的轉變，不僅最大限度地減少了對傳統醫院就診的依賴，還提高了患者的參與度，並促進了個人化治療方案的發展。因此，人工智慧正在成為無症狀性領域早期診斷和改善健康結果的關鍵驅動力。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球無症狀性心肌梗塞市場規模：依診斷分類。

• 心電圖（ECG）
• 驗血
• 心臟影像
• 其他

全球無症狀性心肌梗塞市場規模：依治療方法分類。

• 藥物治療
• 經皮冠狀動脈介入治療（PCI）
• 冠狀動脈繞道手術手術（CABG）

全球無症狀性心肌梗塞市場規模：依風險組別分類

• 糖尿病患者
• 老年人
• 心血管疾病高風險患者
• 其他

全球無症狀性心肌梗塞市場規模：依最終用戶分類。

• 醫院
• 循環系統診所
• 診斷中心

全球無症狀性心肌梗塞市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球無症狀性心肌梗塞市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Koninklijke Philips NV
• Canon Inc.
• FUJIFILM Holdings Corporation
• Samsung Medison Co., Ltd.
• Hitachi, Ltd.
• HeartFlow, Inc.
• AliveCor, Inc.
• iRhythm Technologies, Inc.
• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Nihon Kohden Corporation
• Baxter International Inc.
• Cardiac Insight, Inc.

結論與建議

Global Silent Heart Attack Market size was valued at USD 7.83 Billion in 2024 and is poised to grow from USD 8.37 Billion in 2025 to USD 14.27 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The market for silent heart attack solutions encompasses diagnostics, monitoring devices, and therapies aimed at undetected myocardial infarctions, which often lack traditional chest-pain symptoms. With a significant percentage of heart attacks remaining unnoticed, the demand for early intervention tools like wearable ECG patches and AI risk-scoring systems has surged, highlighting the cost-saving potential for both patients and clinicians. This trend signifies a transformation from reactive to proactive cardiovascular health management. Regulatory support for preventive cardiology is a key driver of growth, as governments acknowledge that early detection minimizes long-term healthcare costs. Initiatives, including reimbursement for high-sensitivity troponin assays and endorsement of remote monitoring systems, have encouraged manufacturers to enhance production and invest in innovation, ultimately improving patient outcomes and attracting insurers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Silent Heart Attack market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Silent Heart Attack Market Segments Analysis

Global silent heart attack market is segmented by diagnosis, treatment, risk group, end user, distribution channel and region. Based on diagnosis, the market is segmented into Electrocardiogram (ECG), Blood Tests, Cardiac Imaging and Others. Based on treatment, the market is segmented into Medication, Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG). Based on risk group, the market is segmented into Diabetic Patients, Elderly Population, High Cardiovascular Risk Patients and Others. Based on end user, the market is segmented into Hospitals, Cardiology Clinics and Diagnostic Centers. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Silent Heart Attack Market

The growing global population of individuals aged sixty-five and older is leading to a notable increase in the prevalence of asymptomatic myocardial events. This demographic trend has heightened awareness among healthcare professionals and caregivers about the importance of early detection methods. Consequently, there is a rising demand for innovative silent heart attack monitoring devices, predictive analytics, and preventive therapies. This growing interest encourages manufacturers to foster innovation and expand their distribution networks, driving market growth as these advanced tools gain traction in both clinical and home-care environments, thereby enhancing patient outcomes and overall awareness of silent heart attacks.

Restraints in the Global Silent Heart Attack Market

The complex and advanced nature of equipment used for detecting silent heart attacks often leads to high acquisition and maintenance costs for healthcare facilities. Budget constraints, particularly in publicly funded and resource-limited institutions, force management to focus on essential services instead of investing in expensive specialized technologies. This financial strain hinders the adoption of new devices in clinical settings, restricts patient access, and diminishes overall market growth. As a result, manufacturers encounter difficulties in achieving quick market penetration, particularly in emerging economies, without clear evidence of cost-effectiveness or adequate reimbursement support for these innovations.

Market Trends of the Global Silent Heart Attack Market

The Global Silent Heart Attack market is experiencing a significant transformation driven by the integration of AI technology in early detection methodologies. Healthcare providers are adopting advanced algorithms that analyze wearable sensor data to identify subtle indicators of silent myocardial infarctions. By continuously monitoring heart rhythm variability and micro-vascular stress markers, these AI platforms facilitate real-time risk assessment, prompting timely preventive care. This shift towards AI-powered monitoring not only minimizes the dependence on traditional clinical visits but also enhances patient engagement and cultivates personalized treatment approaches. Consequently, AI emerges as a pivotal force for earlier diagnosis and better health outcomes in the silent heart attack landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Silent Heart Attack Market Size by Diagnosis & CAGR (2026-2033)

• Market Overview
• Electrocardiogram (ECG)
• Blood Tests
• Cardiac Imaging
• Others

Global Silent Heart Attack Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Medication
• Percutaneous Coronary Intervention (PCI)
• Coronary Artery Bypass Grafting (CABG)

Global Silent Heart Attack Market Size by Risk Group & CAGR (2026-2033)

• Market Overview
• Diabetic Patients
• Elderly Population
• High Cardiovascular Risk Patients
• Others

Global Silent Heart Attack Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiology Clinics
• Diagnostic Centers

Global Silent Heart Attack Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Silent Heart Attack Market Size & CAGR (2026-2033)

• North America (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
  • US
  • Canada
• Europe (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnosis, Treatment, Risk Group, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HeartFlow, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iRhythm Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Insight, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations